POINT Biopharma Global Inc. (PNT) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
4850 WEST 78TH STREET INDIANAPOLIS, IN 46268 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 525,212 | 238,816 | 1,095 | |||
| Cash and cash equivalents | 286,428 | 238,816 | 1,095 | |||
| Short-term investments | 238,783 | |||||
| Receivables | ||||||
| Prepaid expense | 1,310 | 2,175 | 106 | |||
| Other current assets | 215 | 105 | ||||
| Other undisclosed current assets | 4,085 | 2,750 | ||||
| Total current assets: | 530,823 | 243,847 | 1,201 | |||
| Noncurrent Assets | ||||||
| Operating lease, right-of-use asset | ||||||
| Property, plant and equipment | 31,381 | 19,412 | ||||
| Long-term investments and receivables | 16,119 | |||||
| Long-term investments | 16,119 | |||||
| Accounts and financing receivable, after allowance for credit loss | ||||||
| Asset, held-in-trust | 135,706 | |||||
| Other undisclosed noncurrent assets | ||||||
| Total noncurrent assets: | 47,500 | 19,412 | 135,706 | |||
| TOTAL ASSETS: | 578,323 | 263,259 | 136,907 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 26,798 | 7,980 | 118 | |||
| Taxes payable | ✕ | ✕ | 251 | |||
| Accounts payable | 7,703 | 1,738 | 5 | |||
| Accrued liabilities | 19,094 | 5,991 | 113 | |||
| Deferred revenue | 23,242 | |||||
| Debt | ||||||
| Other undisclosed current liabilities | 29,699 | |||||
| Total current liabilities: | 79,738 | 7,980 | 118 | |||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation | ||||||
| Finance lease, liability | ||||||
| Liabilities, other than long-term debt | 11,631 | 66 | ||||
| Accounts payable and accrued liabilities | 1,452 | |||||
| Deferred revenue | 10,178 | |||||
| Deferred income tax liabilities | 66 | |||||
| Operating lease, liability | ||||||
| Other undisclosed noncurrent liabilities | 4,750 | |||||
| Total noncurrent liabilities: | 11,631 | 66 | 4,750 | |||
| Total liabilities: | 91,369 | 8,046 | 4,867 | |||
| Temporary equity, carrying amount | 127,040 | |||||
| Equity | ||||||
| Equity, attributable to parent, including: | 486,954 | 255,213 | 5,000 | |||
| Common stock | 11 | 9 | ||||
| Additional paid in capital | 448,392 | 314,489 | 5,311 | |||
| Accumulated other comprehensive loss | (457) | |||||
| Retained earnings (accumulated deficit) | 39,009 | (59,285) | (312) | |||
| Other undisclosed equity, attributable to parent | 0 | |||||
| Total equity: | 486,954 | 255,213 | 5,000 | |||
| TOTAL LIABILITIES AND EQUITY: | 578,323 | 263,259 | 136,907 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
| Revenues | 226,580 | ||||
| Gross profit: | 226,580 | ||||
| Operating expenses | (101,057) | (45,512) | |||
| Other undisclosed operating income | |||||
| Operating income (loss): | 125,522 | (45,512) | |||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 4,064 | (85) | |||
| Income (loss) from continuing operations before income taxes: | 129,586 | (45,597) | |||
| Income tax expense | (31,293) | (306) | |||
| Income (loss) from continuing operations: | 98,293 | (45,902) | |||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (45,902) | ✕ | |
| Net income (loss) available to common stockholders, diluted: | 98,293 | (45,902) | |||
Comprehensive Income ($ in thousands)
| 9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
| Net income (loss): | 98,293 | (45,902) | |||
| Other comprehensive loss | (457) | ||||
| Other undisclosed comprehensive loss | |||||
| Comprehensive income (loss): | 97,836 | (45,902) | |||
| Other undisclosed comprehensive income, net of tax, attributable to parent | |||||
| Comprehensive income (loss), net of tax, attributable to parent: | 97,836 | (45,902) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.